Post-marketing Surveillance (Special Use-results Surveillance) on Treatment With Alhemo
Post-marketing Surveillance (Special Use-results Surveillance) on Treatment With Alhemo
Enrolling by invitation · NCT06831734 · Registry updated 2026-06-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Post-marketing Surveillance (Special Use-results Surveillance) on Treatment With Alhemo | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, X-linked disease, blood coagulation disease, coagulation protein disease, hematologic disorder, hemophilia A, hemophilia B, hemorrhagic disease, hereditary disease, inherited blood coagulation disorder | Enrolling by invitation | Not stated | 2026-06-15 | NCT06831734 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Novo Nordisk A/S | 181 |
23 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.